Department of Paediatrics and Adolescent Medicine, The University of Hong Kong, Hong Kong, China.
Department of Paediatrics and Adolescent Medicine, The University of Hong Kong, Hong Kong, China.
Cell Rep Med. 2023 Feb 21;4(2):100936. doi: 10.1016/j.xcrm.2023.100936. Epub 2023 Jan 23.
Vaccine effectiveness of BNT162b2 and CoronaVac against COVID-19-associated hospitalization and moderate-to-severe disease due to SARS-CoV-2 Omicron BA.2 is studied from the 1.36 million doses administered to 766,601 of 953,400 children aged 3-11 years and adolescents aged 12-18 years in Hong Kong as of April 2022. These vaccines confer substantial protection.
研究了截至 2022 年 4 月在香港为 953400 名 3-11 岁儿童和 12-18 岁青少年中的 766601 人接种的 136 万剂 BNT162b2 和 CoronaVac 疫苗对 COVID-19 相关住院和因 SARS-CoV-2 奥密克戎 BA.2 导致的中重度疾病的有效性。这些疫苗提供了实质性的保护。